ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,137Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 5176

$2.56M Total Retail Price of All Prescriptions

Rank: 24 out of 5176

430 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 21,834 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

69% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

54 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 1,400 1,329 1 15
NEXIUM 944 883 2 16
BYSTOLIC 785 772 3 96
PLAVIX 580 565 4 29
RANEXA 570 561 5 167
METOPROLOL SUCCINATE 514 482 6 11
SYNTHROID 504 491 7 33
BENICAR HCT 489 463 10 8 110
NAMENDA 460 451 9 47
ZOLPIDEM TARTRATE 423 379 10 17
AMLODIPINE BESYLATE 422 393 11 2
DIOVAN HCT 404 382 12 39
TRILIPIX 392 333 10 13 187
CLOPIDOGREL 369 361 14 26
LOVAZA 367 332 15 43
CELEBREX 365 338 16 80
TAMSULOSIN HCL 351 341 17 20
LIDODERM 341 328 18 59
COUMADIN 326 320 19 112
JANUMET 323 303 20 77
FUROSEMIDE 314 308 21 8
DIOVAN 296 290 22 19
VOLTAREN 295 272 23 97
ATELVIA 288 281 24 146
DEXILANT 282 279 25 118
ATORVASTATIN CALCIUM 281 265 26 9
MECLIZINE HCL 259 247 27 81
VESICARE 253 240 28 210
CREON 252 239 29 111
ATENOLOL 249 228 30 12
FLUTICASONE PROPIONATE 237 216 31 38
SYMBICORT 227 199 32 120
AVODART 219 217 33 107
SIMVASTATIN 210 164 34 1
METOPROLOL TARTRATE 207 197 35 6
CARVEDILOL 205 191 36 24
EXFORGE HCT 200 193 37 266
TRIBENZOR 193 193 38 276
CLOBETASOL PROPIONATE 168 158 39 130
SPIRONOLACTONE 167 166 40 88
JANUVIA 160 158 41 25
KOMBIGLYZE XR 152 130 42 291
EXELON 150 150 43 162
LIPITOR 149 144 44 51
GLIMEPIRIDE 143 137 45 37
METFORMIN HCL 143 117 45 7
ONGLYZA 142 142 47 153
BENICAR 142 138 47 100
RANITIDINE HCL 134 121 49 36
DICYCLOMINE HCL 129 116 50 224
EXFORGE 123 118 51 126
OMEPRAZOLE 122 112 52 3
DIGOXIN 120 113 53 56
ACETAMINOPHEN-CODEINE 119 115 S3 54 127
AZITHROMYCIN 117 100 55 42
ISOSORBIDE MONONITRATE ER 115 101 56 44
KETOCONAZOLE 108 104 57 233
HYDROCODONE-ACETAMINOPHEN 105 97 S3 58 27
VIIBRYD 102 96 59 537
ALLOPURINOL 102 87 59 41
PROCTOZONE-HC 96 93 61 171
ULORIC 93 93 62 280
MICARDIS HCT 91 77 63 180
EFFIENT 87 68 64 342
LUNESTA 85 79 65 242
CLONIDINE HCL 85 82 65 79
PRANDIN 81 75 67 150
DICLOFENAC SODIUM 80 74 68 160
SINGULAIR 77 73 69 62
AMMONIUM LACTATE 73 72 70 91
TRAMADOL HCL 70 67 71 40
ESCITALOPRAM OXALATE 69 69 72 89
CIPROFLOXACIN HCL 66 62 73 84
LANSOPRAZOLE 63 59 74 113
AZOR 63 63 74 194
AMITIZA 62 59 76 197
RAMIPRIL 62 46 76 50
TOPROL XL 61 61 78 227
PANTOPRAZOLE SODIUM 60 51 79 61
NITROSTAT 59 59 80 205
IBUPROFEN 58 53 81 72
AGGRENOX 58 58 81 235
TRIAMTERENE-HCTZ 57 57 83 86
DILTIAZEM 24HR CD 57 57 83 119
ZOVIRAX 56 53 85 313
SPIRIVA 56 37 85 54
DALIRESP 55 44 87 466
ACTONEL 55 55 87 134
MATZIM LA 54 44 10 89 531
LOSARTAN-HYDROCHLOROTHIAZIDE 54 42 89 35
PENNSAID 53 53 91 450
LYRICA 53 53 91 133
MICARDIS 51 49 93 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.